These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
70 related articles for article (PubMed ID: 9781026)
1. A complete protein truncation test for BRCA1 and BRCA2. Garvin AM Eur J Hum Genet; 1998; 6(3):226-34. PubMed ID: 9781026 [TBL] [Abstract][Full Text] [Related]
2. BRCA1 and BRCA2 mRNA levels are coordinately elevated in human breast cancer cells in response to estrogen. Spillman MA; Bowcock AM Oncogene; 1996 Oct; 13(8):1639-45. PubMed ID: 8895509 [TBL] [Abstract][Full Text] [Related]
3. Mutational analysis of BRCA1 and BRCA2 genes in Chinese ovarian cancer identifies 6 novel germline mutations. Khoo US; Ngan HY; Cheung AN; Chan KY; Lu J; Chan VW; Lau S; Andrulis IL; Ozcelik H Hum Mutat; 2000 Jul; 16(1):88-9. PubMed ID: 10874312 [TBL] [Abstract][Full Text] [Related]
4. Ovarian cancer BRCA1 mutation detection: Protein truncation test (PTT) outperforms single strand conformation polymorphism analysis (SSCP). Geisler JP; Hatterman-Zogg MA; Rathe JA; Lallas TA; Kirby P; Buller RE Hum Mutat; 2001 Oct; 18(4):337-44. PubMed ID: 11668617 [TBL] [Abstract][Full Text] [Related]
5. Characterization of ten novel and 13 recurring BRCA1 and BRCA2 germline mutations in Italian breast and/or ovarian carcinoma patients. Mutations in brief no. 178. Online. De Benedetti VM; Radice P; Pasini B; Stagi L; Pensotti V; Mondini P; Manoukian S; Conti A; Spatti G; Rilke F; Pierotti MA Hum Mutat; 1998; 12(3):215. PubMed ID: 10660329 [TBL] [Abstract][Full Text] [Related]
6. BRCA1 and BRCA2 have a limited role in familial prostate cancer. Sinclair CS; Berry R; Schaid D; Thibodeau SN; Couch FJ Cancer Res; 2000 Mar; 60(5):1371-5. PubMed ID: 10728701 [TBL] [Abstract][Full Text] [Related]
7. Universal DNA array detection of small insertions and deletions in BRCA1 and BRCA2. Favis R; Day JP; Gerry NP; Phelan C; Narod S; Barany F Nat Biotechnol; 2000 May; 18(5):561-4. PubMed ID: 10802632 [TBL] [Abstract][Full Text] [Related]
8. Mutational analyses of BRCA1 and BRCA2 in Ashkenazi and non-Ashkenazi Jewish women with familial breast and ovarian cancer. Shiri-Sverdlov R; Oefner P; Green L; Baruch RG; Wagner T; Kruglikova A; Haitchick S; Hofstra RM; Papa MZ; Mulder I; Rizel S; Bar Sade RB; Dagan E; Abdeen Z; Goldman B; Friedman E Hum Mutat; 2000 Dec; 16(6):491-501. PubMed ID: 11102978 [TBL] [Abstract][Full Text] [Related]
9. A high-throughput nonisotopic protein truncation test. Gite S; Lim M; Carlson R; Olejnik J; Zehnbauer B; Rothschild K Nat Biotechnol; 2003 Feb; 21(2):194-7. PubMed ID: 12524552 [TBL] [Abstract][Full Text] [Related]
10. Single-strand conformation polymorphism analysis by capillary and microchip electrophoresis: a fast, simple method for detection of common mutations in BRCA1 and BRCA2. Tian H; Jaquins-Gerstl A; Munro N; Trucco M; Brody LC; Landers JP Genomics; 2000 Jan; 63(1):25-34. PubMed ID: 10662541 [TBL] [Abstract][Full Text] [Related]
11. Mutation analysis of the BRCA1 and BRCA2 genes results in the identification of novel and recurrent mutations in 6/16 flemish families with breast and/or ovarian cancer but not in 12 sporadic patients with early-onset disease. Mutations in brief no. 224. Online. Claes K; Machackova E; De Vos M; Mortier G; De Paepe A; Messiaen L Hum Mutat; 1999; 13(3):256. PubMed ID: 10090482 [TBL] [Abstract][Full Text] [Related]
12. BRCA1 and BRCA2 mutations in Turkish breast/ovarian families and young breast cancer patients. Yazici H; Bitisik O; Akisik E; Cabioglu N; Saip P; Muslumanoglu M; Glendon G; Bengisu E; Ozbilen S; Dincer M; Turkmen S; Andrulis IL; Dalay N; Ozcelik H Br J Cancer; 2000 Sep; 83(6):737-42. PubMed ID: 10952777 [TBL] [Abstract][Full Text] [Related]
14. Mutations of the BRCA1 and BRCA2 genes in patients with bilateral breast cancer. Steinmann D; Bremer M; Rades D; Skawran B; Siebrands C; Karstens JH; Dörk T Br J Cancer; 2001 Sep; 85(6):850-8. PubMed ID: 11556836 [TBL] [Abstract][Full Text] [Related]
15. The Brca1 and Brca2 proteins and tumor pathogenesis. Ingvarsson S Anticancer Res; 1999; 19(4B):2853-61. PubMed ID: 10652564 [TBL] [Abstract][Full Text] [Related]
16. Founder BRCA1 mutations and two novel germline BRCA2 mutations in breast and/or ovarian cancer families from North-Eastern Poland. van Der Looij M; Wysocka B; Brozek I; Jassem J; Limon J; Olah E Hum Mutat; 2000 May; 15(5):480-1. PubMed ID: 10790213 [TBL] [Abstract][Full Text] [Related]
17. Germline mutations of BRCA1 and BRCA2 in Korean breast and/or ovarian cancer families. Kang HC; Kim IJ; Park JH; Kwon HJ; Won YJ; Heo SC; Lee SY; Kim KH; Shin Y; Noh DY; Yang DH; Choe KJ; Lee BH; King SB; Park JG Hum Mutat; 2002 Sep; 20(3):235. PubMed ID: 12204006 [TBL] [Abstract][Full Text] [Related]
19. p53 mutation with frequent novel condons but not a mutator phenotype in BRCA1- and BRCA2-associated breast tumours. Crook T; Brooks LA; Crossland S; Osin P; Barker KT; Waller J; Philp E; Smith PD; Yulug I; Peto J; Parker G; Allday MJ; Crompton MR; Gusterson BA Oncogene; 1998 Oct; 17(13):1681-9. PubMed ID: 9796697 [TBL] [Abstract][Full Text] [Related]
20. BRCA1 and BRCA2 mutation status and tumor characteristics in male breast cancer: a population-based study in Italy. Ottini L; Masala G; D'Amico C; Mancini B; Saieva C; Aceto G; Gestri D; Vezzosi V; Falchetti M; De Marco M; Paglierani M; Cama A; Bianchi S; Mariani-Costantini R; Palli D Cancer Res; 2003 Jan; 63(2):342-7. PubMed ID: 12543786 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]